BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11958572)

  • 1. Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death.
    Aringer M; Feierl E; Steiner G; Stummvoll GH; Höfler E; Steiner CW; Radda I; Smole JS; Graninger WB
    Lupus; 2002; 11(2):102-8. PubMed ID: 11958572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway.
    Pitidhammabhorn D; Kantachuvesiri S; Totemchokchyakarn K; Kitiyanant Y; Ubol S
    Clin Rheumatol; 2006 Sep; 25(5):705-14. PubMed ID: 16391890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis.
    Morita C; Horiuchi T; Tsukamoto H; Hatta N; Kikuchi Y; Arinobu Y; Otsuka T; Sawabe T; Harashima S; Nagasawa K; Niho Y
    Arthritis Rheum; 2001 Dec; 44(12):2819-27. PubMed ID: 11762942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ; Yang X; Chen WY; Li XY; Ji YL; Mao HP; Nie J; Yu XQ
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3102-6. PubMed ID: 18269865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
    Nozaki N; Yamaguchi S; Yamaoka M; Okuyama M; Nakamura H; Tomoike H
    J Mol Cell Cardiol; 1998 Oct; 30(10):2003-12. PubMed ID: 9799654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Li X; Liu L; Meng D; Wang D; Zhang J; Shi D; Liu H; Xu H; Lu L; Sun L
    Stem Cells Dev; 2012 Sep; 21(13):2387-94. PubMed ID: 22375903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus.
    Midgley A; McLaren Z; Moots RJ; Edwards SW; Beresford MW
    Arthritis Rheum; 2009 Aug; 60(8):2390-401. PubMed ID: 19644848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus.
    Zhu LJ; Landolt-Marticorena C; Li T; Yang X; Yu XQ; Gladman DD; Urowitz MB; Fortin PR; Wither JE
    J Rheumatol; 2010 Aug; 37(8):1658-66. PubMed ID: 20516030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients.
    Rathore VB; Advani SH; Nadkarni JJ
    Cancer Detect Prev; 1999; 23(3):226-31. PubMed ID: 10337001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
    Aderka D; Wysenbeek A; Engelmann H; Cope AP; Brennan F; Molad Y; Hornik V; Levo Y; Maini RN; Feldmann M
    Arthritis Rheum; 1993 Aug; 36(8):1111-20. PubMed ID: 8393677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.